CSPC CENWAY TIANJIN PHARMACEUTICALS CO LTD DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

CSPC CENWAY TIANJIN PHARMACEUTICALS CO LTD

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

APIs // Active Pharmaceutical Ingredients

5 APIs, 5 USDMF, 1 CEP/COS

DEVELOPMENTS

No Content

Contact Supplier

Related Companies

Cenway Pharmaceuticals Co., Ltd.

Cenway Technologies, Ltd., a high-tech company in pharmaceuticals and its related areas, focuses on research and development, manufacturing and investment. The companies that Cenway invested are focused in pharmaceuticals sector. In the pharmaceutical sector, Cenway owns a formulation factory in Beijing, 2 API factories in Tianjin, and a pharmaceutical marketing company in Jiangxi Province. Cenway has a large scale factory of pharmaceuticals relevant new materials in Zhejiang. Cenway Pharmaceuticals has strong chemical synthesis capabilities, its annual API and pharmaceutical intermediates production capacity is more than 500 tons. In addition to the Chinese market, the products are also exported to the United States, India and the Middle East. Cenway Pharmaceuticals has industrial chromatographic separation equipment which has high quality, low cost and large-scale (annual production of more than 10 tons) characteristics. In the controlled release field, Cenway is the world's second company has complete osmotic pump technology. The accumulated sale revenue of developed Felodipine is 200 million yuan, accounting for 50% of the market. Cenway has the most comprehensive technology in controlled-released formulation commercialization technology. In addition to osmotic pump technology, Cenway has mastered the oral controlled release solid preparations, multi-pellets delivery system, colon targeted technology, rapid-release technology and instant eye gel technology. Cenway is also committed to develop long-acting injection technology and liposome technology. Zhejiang Cenway New Synthetic Materials Co., Ltd., which was registered and established in the Jiaxing Port Economic Development Zone of Zhejiang Province with the registered capital of RMB 500 million, is committed to the petrochemical industry. In Phase One of the whole project, an investment of RMB 980 million and an area of 270, 000m2 have been used to build a butyl rubber plant with an annual output of 50,000mt. The Phase Two and Three, with a planned total investment of RMB 6 billion and total land area of 700,000 m2, will focus on the comprehensive utilization of C4 resources to form a technically advanced production base of synthetic rubbers with a capacity of 500,000mt per annum in the Yangtze River Delta region. Cenway always plays a leading role in its invested areas. CSPC Cenway is the world's largest GCLE (oral cephalosporin intermediate) supplier, accounting for more than 40% of global market share. Cenway invested in Beijing TINAVI Co., Ltd. is the only company in R & D and production of orthopedics robotics and computer-assisted navigation system. Beijing Jenkem Technology Co., Ltd., a leading global PEG manufacturer, supplies PEG and PEG products for the global pharmaceutical and medical device companies.